TrialAnnals of hematology2023

An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial.

Maria Tsilika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.